| Gene symbol | XIAP | Synonyms | API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq25 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | X-linked inhibitor of apoptosis | ||||
| GTO ID | GTC1281 |
| Trial ID | NCT00557596 |
| Disease | Pancreatic Cancer |
| Altered gene | XIAP |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | AEG35156 |
| Phase | Phase1|Phase2 |
| Recruitment status | Terminated |
| Title | A Phase 1-2, Multicenter, Open-Label Study of The X-Linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 Given in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer |
| Year | 2007 |
| Country | United States |
| Company sponsor | Aegera Therapeutics |
| Other ID(s) | AEG35156-201 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||